Babylon, a UK start-up, plans to “put an accessible and affordable health service in the hands of every person on earth” by putting artificial intelligence (AI) tools to work. Currently, the company has operations in the UK and Rwanda and hopes to expand to the Middle East, the United States, and China. The company’s strategy is to combine the power of AI with the medical expertise of humans to deliver unparalleled access to healthcare.
Services Babylon Offers
Babylon’s engineers, doctors, and scientists developed an AI system that can receive data about the symptoms someone is suffering from, compare the information to a database of known conditions and illnesses to find possible matches, and then identify a course of action and related risk factors. People can use the “Ask Babylon” feature to inquire about their medical concerns to get an initial understanding of what they might be dealing with, but this service is not intended to replace the expertise of a doctor or be used in a medical emergency.
In pursuit of its mission, Babylon offers a “talk to a doctor” service via its app, GP at Hand that provides 24/7 access to healthcare professionals through video or audio conferencing. The app can be downloaded from Google Play or the App Store. At the consultation, doctors can give medical advice, answer questions, discuss treatment, and can order prescriptions that can be delivered to a patient’s door. All of the patient’s clinical records are stored in a secure environment, and their health history can be accessed and referenced when it’s needed. If a patient needs to revisit their appointment, they can review the medical notes and replay a recording of the appointment at any time.
Another feature that is available on the app is Healthcheck. Built with the support of doctors, scientists and disease experts, this AI tool can take answers from questions about family history and a person’s lifestyle and compare it to the medical database to then create a health report and insights to help someone stay healthy.
Image Credit: Alias Studio/ Amanda Scott
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News This Week
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]
CRISPR gene-edited immune cells have been injected into three people with advanced cancer without any serious side effects, the first trial of its kind in the US. It is also the first CRISPR cancer [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - February 9 2020 Since [...]
Frank Boehm (NanoApps Medical Inc. founder) and Amanda Scott (NA CEO) join NanoApps Athletics Inc. NanoApps Athletics Inc proposes a unique synergistic biochemical/nanomedical strategy for the expedited repair and healing of Achilles tendon micro [...]
In her inaugural podcast, Jamilee interviews Frank Boehm of NanoApps Medical Inc and NanoApps Athletics Inc. From Jamilee's podcast: Welcome to the first episode of "In a Click". On todays show I chat with [...]
Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles, each containing up to six different materials and eight segments, [...]